Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP650494.RAl7gdmvWPOR3RIknnKmTkLPPQoMkk4D2UuO4iOP1CZ3c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP650494.RAl7gdmvWPOR3RIknnKmTkLPPQoMkk4D2UuO4iOP1CZ3c130_assertion type Assertion NP650494.RAl7gdmvWPOR3RIknnKmTkLPPQoMkk4D2UuO4iOP1CZ3c130_head.
- NP650494.RAl7gdmvWPOR3RIknnKmTkLPPQoMkk4D2UuO4iOP1CZ3c130_assertion description "[Among 18 BCR-ABL+ leukemias presenting acquired trisomy of chromosome 21, we report a high frequency (33%) of recurrent point mutations (4 in myeloid blast crisis [BC] CML and one in chronic phase CML) within the DNA-binding region of RUNX1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650494.RAl7gdmvWPOR3RIknnKmTkLPPQoMkk4D2UuO4iOP1CZ3c130_provenance.
- NP650494.RAl7gdmvWPOR3RIknnKmTkLPPQoMkk4D2UuO4iOP1CZ3c130_assertion evidence source_evidence_literature NP650494.RAl7gdmvWPOR3RIknnKmTkLPPQoMkk4D2UuO4iOP1CZ3c130_provenance.
- NP650494.RAl7gdmvWPOR3RIknnKmTkLPPQoMkk4D2UuO4iOP1CZ3c130_assertion SIO_000772 18202228 NP650494.RAl7gdmvWPOR3RIknnKmTkLPPQoMkk4D2UuO4iOP1CZ3c130_provenance.
- NP650494.RAl7gdmvWPOR3RIknnKmTkLPPQoMkk4D2UuO4iOP1CZ3c130_assertion wasDerivedFrom befree-2016 NP650494.RAl7gdmvWPOR3RIknnKmTkLPPQoMkk4D2UuO4iOP1CZ3c130_provenance.
- NP650494.RAl7gdmvWPOR3RIknnKmTkLPPQoMkk4D2UuO4iOP1CZ3c130_assertion wasGeneratedBy ECO_0000203 NP650494.RAl7gdmvWPOR3RIknnKmTkLPPQoMkk4D2UuO4iOP1CZ3c130_provenance.